Taiwan’s National Science and Technology Council Minister Wu Cheng-wen has announced that an understanding has been established between Taiwan and the United States regarding the exemption of semiconductor products from…
The Finance Herald
China finds itself preparing another round of property market interventions as the nation’s real estate sector approaches its sixth consecutive year of decline. Alongside Japan’s planned $150 billion fiscal stimulus…
Moderna’s Strategic Vision: Pioneering Revenue Growth and Expanding Vaccine Innovations Through 2028
Moderna outlined its three-year strategic plan and pipeline developments during an Analyst Day presentation, projecting revenue growth reaching 10 percent in 2026 while making progress toward achieving cash flow breakeven…
The competitive pursuit of Avadel Pharmaceuticals has intensified, with Alkermes presenting a revised acquisition proposal worth up to $22.50 per share. This enhanced bid comes after Lundbeck submitted an unexpected…
Agios Pharmaceuticals experienced a significant stock decline following the release of Phase 3 clinical trial data for its anemia medication Pyrukynd on Wednesday, November 19, 2025. The experimental treatment showed…
Antibiotic resistance may be creating one of the biggest crises and opportunities, in modern medicine, and companies like BiomX (NYSE:PHGE) could be sitting at the center of the solution. Using…
From Tel Aviv to San Francisco, the AI-coding boom is reshaping how software is built and exposing startups to global security risks Across San Francisco, Tel Aviv, Bangalore and Berlin,…
As concerns over America’s fragile power grid grow, a little-known microcap, Duke Robotics (OTCQB: DUKR), is emerging as an innovative player to watch. The company’s drone technology clean and maintain…
Your Salesforce CPQ contract renewal is approaching. For many revenue leaders, this moment triggers a familiar pattern: assess current performance, negotiate pricing, sign for another term, and move on. But…
2025 marked a turning point for Inspira Technologies (NASDAQ: IINN). The company’s FDA-cleared INSPIRA ART100 system, which delivers extracorporeal life support through advanced blood oxygenation, made the leap from concept…